|1.||Wulf, H C: 6 articles (06/2012 - 12/2003)|
|2.||Calzavara-Pinton, P G: 4 articles (05/2014 - 08/2002)|
|3.||Wiegell, S R: 4 articles (05/2011 - 05/2006)|
|4.||Moan, Johan: 4 articles (06/2007 - 02/2006)|
|5.||Szeimies, R-M: 3 articles (07/2015 - 05/2008)|
|6.||Warloe, T: 3 articles (05/2010 - 09/2001)|
|7.||Weightman, W: 3 articles (05/2008 - 06/2003)|
|8.||Spelman, L: 3 articles (05/2008 - 06/2003)|
|9.||Karrer, S: 2 articles (07/2015 - 08/2002)|
|10.||Zane, C: 2 articles (05/2014 - 08/2002)|
07/01/2004 - "No reduction in the size or number of actinic keratoses was observed in one area treated with methyl aminolaevulinate and in all placebo-treated areas. "
07/01/2015 - "A study of topical methyl-aminolaevulinate red-light photodynamic therapy in the treatment of actinic keratosis in Chinese patients: a Singaporean experience."
04/01/2013 - "Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis."
05/01/2011 - "A randomized, multicentre study of directed daylight exposure times of 1½ vs. 2½ h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp."
04/01/2013 - "Long-term follow-up of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis."
|2.||Basal Cell Carcinoma (Rodent Ulcer)
04/01/2014 - "The model is applied to a basal cell carcinoma treated by Metvix topical photosensitizer protocol. "
06/01/2011 - "Fluorescence diagnostics of basal cell carcinomas comparing methyl-aminolaevulinate and aminolaevulinic acid and correlation with visual clinical tumour size."
01/01/2013 - "Reflectance confocal microscopy allows in vivo real-time noninvasive assessment of the outcome of methyl aminolaevulinate photodynamic therapy of basal cell carcinoma."
04/01/2005 - "Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma."
04/01/2007 - "In several randomized, controlled studies, the application of a standard preparation containing methyl-aminolevulinate (MAL; Metvix, Galderma, F), followed by red light irradiation proved effective and well tolerated in the treatment of actinic keratosis and basal cell carcinoma, and has now been approved for clinical use in European countries. "
01/01/2013 - "Efficacy of red light alone and methyl-aminolaevulinate-photodynamic therapy for the treatment of mild and moderate facial acne."
09/01/2006 - "Topical methyl aminolaevulinate photodynamic therapy for treatment of facial acne vulgaris: results of a randomized, controlled study."
10/01/2007 - "Photodynamic therapy of acne using methyl aminolaevulinate diluted to 4% together with low doses of red light."
05/01/2006 - "Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, controlled trial."
05/01/2006 - "To evaluate the efficacy and tolerability of methyl aminolaevulinate-based photodynamic therapy (MAL-PDT) in patients with moderate to severe facial acne vulgaris in a randomized, controlled and investigator-blinded trial. "
|4.||Bowen's Disease (Disease, Bowen)
02/01/2005 - "Methyl aminolaevulinate photodynamic therapy for Bowen's disease: a practical option?"
01/01/2014 - "A randomized trial comparing methyl aminolaevulinate photodynamic therapy with and without Er:YAG ablative fractional laser treatment in Asian patients with lower extremity Bowen disease: results from a 12-month follow-up."
12/01/2014 - "Four patients with biopsy-proven Bowen' disease were treated with Metvix PDT between November 2010 and January 2012. "
01/01/2014 - "Methyl aminolaevulinate photodynamic therapy (MAL-PDT) is an effective treatment for Bowen disease (BD) of the lower extremities. "
12/01/2014 - "To evaluate the response of Metvix photodynamic therapy (PDT) for the treatment of periocular Bowen's disease. "
|4.||Photosensitizing Agents (Photosensitizers)
|1.||Photochemotherapy (Photodynamic Therapy)
|2.||Transplantation (Transplant Recipients)
|3.||Cryotherapy (Therapy, Cold)